Prosecution Insights
Last updated: October 25, 2026

Alexandria Biotech, LLC

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Alexandria Biotech, LLC currently manages 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is being handled by 1 distinct examiner, indicating a highly centralized prosecution effort. The presence of 1 distinct art unit suggests that the company's current patent activity is focused within a specific technical domain of the medical devices sector.

The busiest examiner for Alexandria Biotech, LLC is NELSON, KERI JESSICA, who is responsible for 1 pending office action. Because there is only 1 distinct examiner involved in the entire portfolio, the prosecution strategy is entirely dependent on the interactions with this specific individual. Practitioners should note that the lack of diversity in examiners and art units means there are no alternative prosecution tracks currently active.

The alignment of 1 pending office action with 1 distinct examiner and 1 distinct art unit creates a streamlined prosecution environment. Practitioners can focus resources on the specific requirements of NELSON, KERI JESSICA without the complexity of navigating multiple examiner preferences. This singular focus is characteristic of the current Alexandria Biotech, LLC portfolio structure within Medical Devices & Mechanical Engineering.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NELSON, KERI JESSICA 1 58.6% +41.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19213498 ADAPTABLE COMPRESSION SYSTEM FOR TREATING HYPOTENSION CRISIS EVENTS AND RELATED DEVICES AND METHODS NELSON, KERI JESSICA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19213498 ADAPTABLE COMPRESSION SYSTEM FOR TREATING HYPOTENSION CRISIS EVENTS AND RELATED DEVICES AND METHODS NELSON, KERI JESSICA —

Top Art Units

Art UnitApps
3786 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19213498 ADAPTABLE COMPRESSION SYSTEM FOR TREATING HYPOTENSION CRISIS EVENTS AND RELATED DEVICES AND METHODS NELSON, KERI JESSICA 3786 §102§103§112 Non-Final OA — Pending May 20, 2025

Managing Alexandria Biotech, LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Alexandria Biotech, LLC have?

Alexandria Biotech, LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Alexandria Biotech, LLC applications?

Keri Jessica Nelson has the most, with 1 of Alexandria Biotech, LLC's pending office actions.

What technology area are Alexandria Biotech, LLC's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month